$3.75
0.61[19.43%]
At close: Apr 26
$3.75
0[0.00%]
After Hours: 7:49PM EDT
NRX Pharmaceuticals
(NASDAQ:NRXP)NRX Pharmaceuticals Stock (NASDAQ:NRXP), Insider Trading Activity
NRX Pharmaceuticals: Insider buying and selling updated today.
Shares Outstanding
10.488M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Aaron Gorovitz | 35K | $0.32 | $11.20K | BUY | 50.00% | 105K | Aug 30 | View | |
| Sep 11, 2023 | Chaim Hurvitz | 70K | $0.29 | $20.13K | BUY | 9.88% | 778.443K | Aug 30 | View | |
| Aug 24, 2023 | Jonathan C Javitt | CHIEF SCIENTIST | 100K | $0.33 | $33.00K | BUY | 15.47% | 746.332K | Aug 23 | View |
| Aug 23, 2023 | Jonathan C Javitt | CHIEF SCIENTIST | 200K | $0.32 | $64.40K | BUY | 44.81% | 646.332K | Aug 22 | View |
| Dec 19, 2022 | Stephen Willard | CHIEF EXECUTIVE OFFICER | 50K | $1.17 | $58.50K | BUY | ∞ | 50K | Dec 16 | View |
| Dec 19, 2022 | Seth Van Voorhees | CHIEF FINANCIAL OFFICER | 30K | $1.10 | $33.00K | BUY | 183.63% | 46.337K | Dec 16 | View |
| Dec 09, 2022 | Jonathan C Javitt | -400K | $1.00 | -$400.00K | SELL | -2.97% | 13.046329M | Dec 07 | View | |
| Dec 01, 2022 | Daniel Javitt | 10% OWNER | -22.171K | $1.50 | -$33.35K | SELL | -0.23% | 9.634793M | Nov 29 - Nov 30 | View |
| Nov 29, 2022 | Patrick J Flynn | 11.75K | $1.25 | $14.66K | BUY | ∞ | 1.75K | Nov 28 | View | |
| Nov 28, 2022 | Seth Van Voorhees | CHIEF FINANCIAL OFFICER | 16.337K | $1.11 | $18.22K | BUY | 40842.50% | 16.377K | Nov 25 | View |
| Nov 21, 2022 | Chaim Hurvitz | DIRECTOR | 500K | $1.03 | $514.91K | BUY | 239.87% | 708.443K | Nov 16 - Nov 18 | View |
| Nov 18, 2022 | Daniel Javitt | 10% OWNER | -166.737K | $1.03 | -$171.14K | SELL | -1.70% | 9.656964M | Nov 16 - Nov 17 | View |
| Nov 15, 2022 | Daniel Javitt | 10% OWNER | -49.2K | $1.01 | -$49.51K | SELL | -0.50% | 9.823701M | Nov 11 | View |
| Aug 02, 2022 | Daniel Javitt | 10% OWNER | -784.063K | $1.01 | -$791.43K | SELL | -7.36% | 9.872901M | Jul 29 | View |
| Jun 07, 2022 | Daniel Javitt | 10% OWNER | -445.712K | $0.68 | -$303.91K | SELL | -3.40% | 12.656964M | Jun 03 - Jun 07 | View |
| Jun 02, 2022 | Jonathan C Javitt | CHIEF SCIENTIST | 100K | $58.00 | $5.80M | BUY | 6.81% | 1.568332M | Jun 01 | View |
| Nov 02, 2021 | Alessandra Daigneault | GENERAL COUNSEL & SECRETARY | 25.264K | $8.09 | -$260.94K | SELL-OPTIONS | 399.75% | 31.584K | Aug 19 - Sep 02 | View |
| Nov 02, 2021 | Robert Besthof | CHIEF COMM. & PATIENT OFFICER | 23.71K | $5.98 | -$457.66K | SELL-OPTIONS | ∞ | 23.71K | Aug 16 - Sep 15 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.